|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/336 | |||
| A61K 31/404 | |||
| C07D 409/12 | |||
| C07D 303/32 | |||
| A61P 37/00 |
| (11) | Number of the document | 2970225 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14723553.5 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/026980 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152127 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361785608 P | 2013-03-14 | US | |
| 201361786086 P | 2013-03-14 | US | |
| 201361847780 P | 2013-07-18 | US | |
| 201361856847 P | 2013-07-22 | US | |
| 201361883798 P | 2013-09-27 | US | |
| 201361883843 P | 2013-09-27 | US | |
| 201461941798 P | 2014-02-19 | US |
| (72) |
MCMINN, Dustin, US
JOHNSON, Henry, US
MOEBIUS, David, C., US
|
| (73) |
Onyx Therapeutics, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (54) | DIPEPTIDE AND TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS |
| DIPEPTIDE AND TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS |